Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | aldehyde dehydrogenase 1 family, member A1 | Starlite/ChEMBL | No references |
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Homo sapiens | breast cancer 1, early onset | Starlite/ChEMBL | No references |
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Mycobacterium tuberculosis | Succinate-semialdehyde dehydrogenase [NADP+] dependent (SSDH) GabD1 | aldehyde dehydrogenase 1 family, member A1 | 501 aa | 456 aa | 33.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | Steroid hormone receptor family member cnr14 homolog | 0.0012 | 0 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | 3-oxoacyl-ACP synthase | 0.2108 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0138 | 0.6031 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0073 | 0.0292 | 0.5 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.2108 | 1 | 1 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.0033 | 0.112 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0073 | 0.0292 | 1 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0274 | 0.1248 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.0138 | 0.4736 |
Brugia malayi | hypothetical protein | 0.0043 | 0.0149 | 0.6509 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0043 | 0.0149 | 0.5111 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0073 | 0.0292 | 1 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.0033 | 0.112 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.0229 | 1 |
Echinococcus granulosus | GPCR family 2 | 0.0019 | 0.0033 | 0.112 |
Plasmodium falciparum | beta-ketoacyl-ACP synthase III | 0.2108 | 1 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.0229 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0229 | 1 |
Echinococcus multilocularis | GPCR, family 2 | 0.0019 | 0.0033 | 0.112 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0033 | 0.112 |
Onchocerca volvulus | Protein ultraspiracle homolog | 0.0012 | 0 | 0.5 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0019 | 0.0033 | 0.1426 |
Onchocerca volvulus | Bile acid receptor homolog | 0.0012 | 0 | 0.5 |
Mycobacterium tuberculosis | 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) | 0.2108 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0033 | 0.112 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0073 | 0.0292 | 0.5 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.0033 | 0.112 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0033 | 0.1426 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0019 | 0.0033 | 0.1426 |
Onchocerca volvulus | 0.0012 | 0 | 0.5 | |
Entamoeba histolytica | fatty acid elongase, putative | 0.0274 | 0.1248 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.0138 | 0.6031 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0073 | 0.0292 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.0229 | 1 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0274 | 0.1248 | 1 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.0033 | 0.112 |
Mycobacterium ulcerans | beta-ketoacyl synthase-like protein | 0.2108 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0043 | 0.0149 | 0.5111 |
Plasmodium vivax | beta-ketoacyl-acyl carrier protein synthase III precursor, putative | 0.2108 | 1 | 0.5 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.2108 | 1 | 1 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0274 | 0.1248 | 1 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0274 | 0.1248 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0033 | 0.112 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0033 | 0.112 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0043 | 0.0149 | 0.5111 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0019 | 0.0033 | 0.1426 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0043 | 0.0149 | 0.5111 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0073 | 0.0292 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 2.8184 uM | PubChem BioAssay. qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 5.1735 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | = 7.0795 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 8.9125 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | = 11.2202 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 14.7157 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 15.8489 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 20.5962 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 23.1093 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493106, AID493143] | ChEMBL. | No reference |
Potency (functional) | 26.8545 uM | PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.